iTeos Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
13 May 2025	Form 3: EcoR1 Capital, Llc, 10% owner Holds 5,730,000 shares of Common Stock
05 Aug 2024	Form 3: Feltquate David, Chief Medical Officer No securities owned
07 Mar 2024	Form 3: DeSimone Jill, Director No securities owned
07 Dec 2023	Form 3: Lee David K, Director No securities owned
03 May 2021	Form 3: Iannone Robert, Director No securities owned
03 May 2021	Form 3: Ho Tony W, Director No securities owned
12 Nov 2020	Form 3: Roden Matthew, Director No securities owned
23 Jul 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 2 others
23 Jul 2020	Form 3: Hallal David, Director
23 Jul 2020	Form 3: DiRocco Derek, Director No securities owned
23 Jul 2020	Form 3: Mpm BioVentures 2014, L.p., 10% owner and 2 others
23 Jul 2020	Form 3: Van Hauwermeiren Timothy, Director
23 Jul 2020	Form 3: Biniszkiewicz Detlev, Director No securities owned
23 Jul 2020	Form 3: Belawat Priyanka, Director No securities owned
23 Jul 2020	Form 3: Gall Matthew, Chief Financial Officer
23 Jul 2020	Form 3: Detheux Michel, Director Holds 177,937 shares of Common Stock
23 Jul 2020	Form 3: McGrath Yvonne, VP, Research and Development
23 Jul 2020	Form 3: Davis Aaron I., Director
23 Jul 2020	Form 3: Gadicke Ansbert, Director and 4 others
23 Jul 2020	Form 3: Mpm BioVentures 2014, L.p., 10% owner and 9 others

Comments